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Objective: Bipolar I disorder is one of the most frequent mental disorders characterized by manic or mixed +/- 
depressive episodes. Drug treatment has been proved to diminish next episodes, but many other factors are important 
for exacerbating the conditions. This study aimed to investigate the effective factors on the time and number of episodes 
in these patients by applying the shared frailty model. 
Method: In this retrospective longitudinal study, the information of 606 patients with bipolar I disorder, admitted for the 
first time in Ibn-e-Sina psychiatric hospital in Mashhad from the beginning of 2007 until the end of 2009 were used. 
These patients were followed up until the end of 2018 for readmission. The Cox model with gamma frailty and Bayesian 
approach were used to determine the effective factors of frequent recurrences.  
Results: History of head trauma, substance abuse, and legal conflict had a positive impact on recurrences, while age 
had a negative effect on recurrences and the risk of recurrence was higher in younger people (P < 0.05). The variance 
estimation of frailty effect was 0.97 that indicates a correlation between the recurrence intervals of bipolar I patients, 
owing to a heterogeneity among patients. 
Conclusion: Based on the results, a higher risk of recurrence of bipolar I disorder was found in younger patients and 
those with a history of head trauma, substance abuse, and legal conflicts. Further investigations are required to account 
for the genetic factor and psychosocial exposure during critical periods applying this model. 
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Mood disorder is one of the most prevalent 
psychiatric disorders and it is considered as a major 
precluding factor worldwide (1). Bipolar disorder is 
classified as a mood disorder and it is identified by 
episodic changes in the mood (2). The studies related to 
the cost burden of different disorders indicated that the 
financial burden of bipolar disorder is more than the 
other behavioral disorders (3). Bipolar disorder types I 
(BD-I) may be characterized by recurrent episodes of 
mania, mixed or/and depression (4).  
 Based on the Iranian mental health survey, the 
prevalence of BP-I is reported as 1% (5). Despite the 
genetic risks in pathogenesis of this disease (6), it seems 
that different factors can influence the course, 
symptoms, severity, respond to treatment, harmful 
outcomes and recurrence of bipolar disorder (7-13). In 
regard to the chronic nature of this illness, it can have an 
impact on all aspects of patient's life and despite the 
various medical and psychological interventions (14-17), 
it leads to dysfunction in different dimensions (18). 
Also, the recurrence of this disorder is common. Based 
on a study, recurrence occurs during 2 years among 
approximately 50% of patients receiving medical 
treatments (19). The repetitive recurrences included 
higher patients' disability, harm effects, dysfunction, and 
cost burden (20). Therefore, the factors related to 
recurrence should be identified for better management 
and control of the treatment process. Based on the 
previous studies, different factors were suggested as risk 
factors for recurrence, such as type of disorder, time 
after first episode, gender, age, family history, 
nonadherence to treatment, psychiatric comorbidities, 
educational level, marital status, life events, and alcohol 
or substance abuse (20-28). Since there is no study 
concerning the importance of individual characteristics 
as risk factors for the recurrence of bipolar disorder in 
Iran, this study aimed to assess the effective factors on 
the recurrence of bipolar mood disorder I in an Iranian 
population using a frailty model with the Bayesian 
approach. This study was approved by the ethics 
committee of Mashhad University of Medical Sciences 
in Iran with the ethics code of MUMS.REC.1395.101. 
 
Materials and Methods 
This retrospective longitudinal study was conducted on 
606 hospitalized BD-I patients with at least 1 history of 
readmission due to recurrence from the beginning of 
2007 to the end of 2009 in Ibn-e-Sina psychiatric 
hospital (one of the greatest psychiatric hospitals in Iran) 
of Mashhad (Northeast of Iran). The patients were 
followed up for recurrence until the end of 2018. Data 
were collected using the medical records. Recurrence is 
defined by having a new manic, mixed or major 
depressive episode that needs hospitalization and a 
minimum 2-month’s interepisode time. All patients had 
experienced at least an acute manic or mixed episode 
and the diagnosis was based on a semistructured 
interview of 2 psychiatrists based on the DSM-IV-TR 
criteria. The variables including gender, age at onset of 
illness, the obvious stress (individual, business, family), 
marital status, family history, severe head trauma, 
substance abuse, and legal conflicts were recorded and 
analyzed in this study. 
 
Statistical analysis: 
The most common method for survival data analysis is 
Cox proportional hazards model (29).  
The requirement of this model is survival time 
independence. There is a correlation between survival 
times for each person in the cases of diseases with 
recurrence and return probability. This correlation due to 
individual and hereditary characteristics that differ from 
person to person, cannot be measured and incorporated 
into the model. Ignoring this correlation leads to an 
underestimation of the parameters’ estimation (29). To 
eliminate the effect of these factors, they are multiplied 
as random variables by the hazard function that is called 
shared frailty model. 0( | x,u) ( ) exp( )t t u Bx  , 
where is the indicator of known variables vector and is 
the indicator of unknown variables vector with a gamma 
distribution and 0 as a piecewise constant baseline 
hazard function. In this current study, the model is 
specified as :
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In this study, the time from each discharge from the 
hospital until the next episode and readmission was 
considered as survival time. It means the first survival 
time is the time from the first discharge until the second 
admission and the second survival time is the time from 
the second discharge until the third admission and so on. 
The Bayesian approach was applied to estimate the 
parameters of the model. The advantage of this approach 
is that it combines experimental and prior or external 
information via the Bayes theorem for producing the 
posterior distribution that is used to make all inferences 
about the estimate of interest.  
( | ) ~ ( | ) ( )p d data p data d p d , where is the 
parameter of interest. Posterior distribution ~ data 
likelihood prior distribution. In cases where selecting a 
prior distribution is difficult, a prior distribution can be 
selected in which the dominant information in the 
posterior distribution provided by the data, such priors, 
are known as noninformative prior (30). The software 
employed in this analysis was Win BUGS. 
 
Results 
A total of 606 patients with BD-I participated in this 
study, of whom 380 patients (62.7%) were male and 226 
(37.3%) were female. The mean age was 13.25 ± 38.92 
years. A total of 331 patients (54.9%) were married and 
165 (27.2%) had a history of head trauma, 313 (51.8 %) 
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a history of stress. A total of 181 participants (29.9 %) 
had a history of substance abuse and 163 (26.9%) had a 
history of legal conflict. Of these, 115 patients with BD-
I (34.8%) had experienced more than 2 episodes with 
admissions (Table 1).  
In the frailty model, history of head trauma ((95% CI: 
[0.95, 0.98]), history of substance abuse ((95% CI: [0.14, 
0.68]), history of legal conflict ((95% CI: [0.25, 0.77]), 
age ((95% CI: [-0.019, -0.005]), and the frequent 
recurrences of bipolar disorder were significant through 
Bayesian credible intervals, which did not include zero. 
Also, the mean posterior frailty variance was estimated 
to be 0.97 with ((95% CI: [0.79, 1.23]), indicating that 
there was heterogeneity among participants, which was 
significant according to their credible intervals (Table 2).  
 
Table 1. The Frequency and Times of Recurrence among Bipolar I Patients
 
Percent Frequency Recurrence number 
42.1 140 Once 
23.1 77 Twice 
16.26 54 Three times 
6.02 20 Four times 
12.52 41 Five times and more 
 
 
Table 2. Statistical Summary of the Cox Proportional Hazard Shared Gamma Frailty Model among 
Bipolar I Patients
 
Variable Reference Category Mean SE CI 95% 
Age 
 
-0.0156 0.0053 (-0.019, -0.005) 
Head trauma Doesn’t have 0.7418 0.1216 (0.495, 0.980) 
Stress Doesn’t have 0.1941 0.137 (-0.378, 0.1186) 
Sex Male -0.039 0.1012 (-0.2038, 0.086) 
Marital status Single -0.0123 0.137 (-0.378, 0.1186) 
Family history Doesn’t have 0.517 0.1202 (-0.183, 0.270) 
Substance abuse Doesn’t have 0.383 0.13 (0.14, 0.68) 
Legal conflict Doesn’t have 0.4935 0.133 (0.257, 0.777) 
Fragility variance 0.97 0.148 (0.76, 1.23) 
 
Mean: mean posterior distribution; SE: standard deviation; CI 95%: credible interval 95%.  
 
Discussion 
The results of the present study demonstrated that 
history of head trauma, substance abuse, and legal 
conflict had a positive impact on recurrences, while age 
had a negative impact on recurrences. The risk of 
recurrence was higher in younger people. The variance 
estimation of the frailty effect indicated a correlation 
between the recurrence intervals of bipolar I patients, 
which is due to heterogeneity between individuals. In the 
absence of careful longtime management and follow-up, 
many patients with BD-I experience frequent 
recurrences during their lifetime, which has an influence 
not only on the mind and functionality but also on the 
interpersonal and familial status of the patients; and 
finally, more episodes lead to a worse prognosis (31). 
According to the study conducted by Ghoreishizadeh et 
al in Iran, the major factors in the recurrence of bipolar 
disorder were cessation of medical treatment, a decrease 
in the dose of medication, insomnia or irregular sleep, 
lack of knowledge, substance abuse, and lifetime events. 
The results related to substance abuse and negative 
lifetime events are in line with the results of the present 
study (20). Based on the results of Gilman et al study, 
the age of onset and age of first recurrence of BD-I are 
assumed as important prognosis predictors, although 
some studies determined the number of frequent 
recurrences as a more prominent factor (32), while some 
studies do not show significant associations (33,34). In 
this study, the age of onset was proved to be significant, 
so that young patients who had their first experience of 
recurrence were more prone to frequent episodes. The 
negative impact of substance abuse or dependency on 
the prognosis and recurrences of BD-I was determined in 
many studies (35). The highest rate for mood disorders 
(and bipolar disorder) was observed among alcohol and 
other substance abusers (36). A cross-sectional study on 
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30 patients with BD-I showed that suicide and lack of 
medications followed by frequent recurrences were 
higher in patients with substance abuse (37). These 
results support the present findings about the effect of 
age and substance abuse in the recurrence of bipolar 
disorder. Taheri et al applied the penalized likelihood 
models for analyzing the time between recurrences for 
patients with BD-I and determined that age, marital 
status, and history of substance abuse were significant 
factors. Moreover, the family history was an effective 
factor in the onset and recurrences of bipolar disorder 
(38, 39). However, in some studies there were not any 
significant relationships between age, family history, and 
marital status with the rate of recurrence (21). Antypa et 
al reported a lower age of the disorder onset and the risk 
of frequent recurrences in BD-I patients with the family 
history of bipolar disorders (39). A study in London 
revealed that the first episode in males on average is 3.8 
years earlier than in females (40). The prevalence of 
bipolar disorder in females is higher than in males (41) 
and females experience more frequent episodes (42). In 
the study of Kennedy et al, gender differences in 
different age groups were not significant and the rate of 
prevalence of BD-I in females, except for the age group 
(16-25 years), was higher (43). In this study, the 
frequency of disorder in males was higher compared to 
females (62.7% vs 37.2%) and sex was not recognized 
significant in the frequent recurrences of the disorder. In 
Iran, just like other developing countries, many episodes 
are often managed in the family environment, so cases 
with severe aggression and hard to control manic 
episodes are hospitalized. This issue can suggest why 
most of readmitted patients are men and the incidence of 
recurrence is higher in men than in women. Mood 
disorders are common in those who have the history of 
brain injury or head trauma, and the risk of mental 
disorder incidence is significantly higher in the head 
trauma cases. The rate of bipolar disorder after a 
traumatic brain injury varied between 1.7% and 17% 
(44, 45). A literature review study on case control, 
cohort, cross-sectional and case reports during 1966 to 
2003 showed that brain injury after birth is considered as 
a risk factor for mood disorders (44). In this study, 
patients with a history of head trauma and brain injury 
experience significantly more recurrences . 
Stress and environmental conditions have a direct 
intensifying role in mental disorders and patients should 
reduce the social and psychological stress to prevent 
more episodes. However, these variables were not 
considered significant in this study and in the study by 
Taheri et al (38).  
 
Limitation 
The present study had some limitations, such as its 
retrospective approach, which limited the exact 
assessment of most factors, such as stressors, medication 
dose, cessation of medical therapy, and other 
comorbidities. It is recommended that future studies 
investigate these factors in addition to variables such as 




In this paper, we considered the characteristics of Cox 
risk model with shared frailty effect on the intervals 
between BD-I recurrences, in which age, head injury, 
substance abuse, and legal conflicts were significant in 
the frequent recurrences of the disorder. More studies 
are required to account for the genetic factor and 
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